Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples